E. ERDAL Et Al. , "Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle," International Journal of Pharmaceutics , vol.645, 2023
ERDAL, E. Et Al. 2023. Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle. International Journal of Pharmaceutics , vol.645 .
ERDAL, E., BAKICI, C., Arslan, A., BATUR, B., YAMAN, M. E., Alçığır, M. E., ... AKYOL, M.(2023). Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle. International Journal of Pharmaceutics , vol.645.
ERDAL, EBRU Et Al. "Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle," International Journal of Pharmaceutics , vol.645, 2023
ERDAL, EBRU Et Al. "Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle." International Journal of Pharmaceutics , vol.645, 2023
ERDAL, E. Et Al. (2023) . "Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle." International Journal of Pharmaceutics , vol.645.
@article{article, author={EBRU ERDAL Et Al. }, title={Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle}, journal={International Journal of Pharmaceutics}, year=2023}